Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on Merck & Co (NYSE:MRK) in the last three months.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Merck & Co, presenting an average target of $135.35, a high estimate of $148.00, and a low estimate of $104.00. This upward trend is apparent, with the current average reflecting a 2.54% increase from the previous average price target of $132.00.

Decoding Analyst...